We just received data on a new analyst forecast for $ABVX. Steve Fleishman from Wolfe Research set a price target of 176.0 for ABVX.
To track analyst ratings and price targets for $ABVX, check out Quiver Quantitative's $ABVX forecast page.
Should you buy $ABVX?
Some analysts are better than others. To view the past performance of Wolfe Research, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$ABVX Price Targets
Multiple analysts have issued price targets for $ABVX recently. We have seen 10 analysts offer price targets for $ABVX in the last 6 months, with a median target of $113.0.
Here are some recent targets:
- Steve Fleishman from Wolfe Research set a target price of $176.0 on 11/06/2025
- Etzer Darout from Barclays set a target price of $142.0 on 10/13/2025
- Yatin Suneja from Guggenheim set a target price of $150.0 on 10/10/2025
- Julian Harrison from BTIG set a target price of $120.0 on 10/07/2025
- Jason N. Butler from JMP Securities set a target price of $114.0 on 09/25/2025
- Judah Frommer from Morgan Stanley set a target price of $101.0 on 09/12/2025
- Allison Bratzel from Piper Sandler set a target price of $112.0 on 07/29/2025
$ABVX Hedge Fund Activity
We have seen 46 institutional investors add shares of $ABVX stock to their portfolio, and 19 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- OCTAGON CAPITAL ADVISORS LP added 1,267,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $9,692,550
- ALLOSTERY INVESTMENTS LP removed 932,304 shares (-84.8%) from their portfolio in Q2 2025, for an estimated $7,132,125
- JPMORGAN CHASE & CO removed 907,679 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $6,943,744
- ADAR1 CAPITAL MANAGEMENT, LLC added 861,321 shares (+39.0%) to their portfolio in Q2 2025, for an estimated $6,589,105
- SAMSARA BIOCAPITAL, LLC removed 425,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $3,251,250
- CALIGAN PARTNERS LP added 405,281 shares (+31.9%) to their portfolio in Q2 2025, for an estimated $3,100,399
- GREAT POINT PARTNERS LLC removed 346,494 shares (-21.2%) from their portfolio in Q2 2025, for an estimated $2,650,679
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
